Pfizer to expand Michigan manufacturing site to support Paxlovid rollout: report

SourceFierce Pharma
Date Published05/25/2022
Author NameZoey Becker
Mentions specific company case(s) of reshoring, kept from offshoring, or transplantYes

Additional Reshoring Information:

Company/Division name Pfizer Inc.
Parent companyPfizer
Type of work Manufacturing
Reshoring category:Reshoring
Year reshoring announced:2022
Domestically, the work will be done:In-house
Capital investment ($):800
City reshored to:Kalamazoo
State(s) reshored to:MI
If relevant, work nearshored to:-
Product(s) reshoredPharmaceutical ingredients, drug products
What non-domestic negative factors made offshoring less attractive?Supply chain interruption risk/Natural disaster risk/Political instability
What domestic positive factors made reshoring more attractive?Skilled workforce availability/training
Find Reshoring Articles